Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.12T | 2.08T | 2.00T | 1.96T | 2.58T |
Gross Profit | 155.04B | 150.31B | 147.45B | 135.16B | 170.39B |
EBITDA | 46.51B | 45.16B | 37.24B | 31.62B | 27.12B |
Net Income | 23.17B | 22.58B | 17.13B | 13.95B | 11.08B |
Balance Sheet | |||||
Total Assets | 775.15B | 794.25B | 707.50B | 665.18B | 684.28B |
Cash, Cash Equivalents and Short-Term Investments | 103.36B | 832.00M | 443.00M | 205.00M | 438.00M |
Total Debt | 5.56B | 5.27B | 5.42B | 6.12B | 6.59B |
Total Liabilities | 556.28B | 590.38B | 524.89B | 494.89B | 487.28B |
Stockholders Equity | 218.05B | 203.84B | 182.59B | 170.16B | 196.88B |
Cash Flow | |||||
Free Cash Flow | 5.88B | 47.09B | 15.64B | 8.37B | 14.63B |
Operating Cash Flow | 11.74B | 55.96B | 24.50B | 19.28B | 23.83B |
Investing Cash Flow | -12.38B | -7.73B | -11.24B | -11.83B | -6.26B |
Financing Cash Flow | -9.01B | -7.30B | -5.74B | -39.65B | -5.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥70.65B | 16.95 | ― | 42.14% | 14.97% | ||
77 Outperform | ¥132.07B | 15.10 | 1.36% | 3.68% | 29.25% | ||
71 Outperform | ¥10.02B | 10.11 | 2.28% | 3.37% | -28.80% | ||
69 Neutral | ¥70.10B | 23.76 | 1.29% | 6.84% | -13.41% | ||
68 Neutral | ¥274.72B | 11.49 | 2.93% | 1.49% | 6.34% | ||
53 Neutral | C$5.40B | 6.74 | 11.95% | 3.32% | 4.99% | -1.01% |